Below is a list of speakers for the HSPH Centennial Leadership Summit on October 25, 2013.
Theresa Betancourt, SD ’03, associate professor of child health and human rights at HSPH, is an expert whose work occurs at the intersection of human rights and mental health, focusing primarily on children in impoverished and crisis settings. She directs the Research Program on Children and Global Adversity at HSPH’s Francois-Xavier Bagnoud Center for Health and Human Rights. In addition, she currently serves as Principal Investigator of an ongoing longitudinal study of former child soldiers in Sierra Leone, and is collaborating with Partners in Health Rwanda to study the impact of a family-based preventive intervention to address mental health needs among HIV/AIDS-affected children and youth. In addition to her doctoral degree from HSPH in maternal and child health and her post-doctoral fellowship in psychiatric epidemiology and biostatistics, she previously worked as a mental health clinician in both school and community settings. Learn more about her work with child soldiers.
Gro Harlem Brundtland, MD, MPH ’65, is Deputy Chair of The Elders and Former Prime Minister of Norway. For over four decades, Dr. Brundtland has been dedicated to global interdependence, focusing on promoting sustainable development, increasing environmental awareness, and advocating for good health as a basic human right. Dr. Brundtland spent ten years as a physician and scientist, and twenty years in public office. She served as Prime Minister of Norway for more than ten years, and was the first woman and the youngest person to ever do so. She was Chair of the World Commission of Environment and Development, and the first woman Director-General of the World Health Organization. The guiding force behind the “Brundtland Report” on sustainability over 25 years ago, Dr. Brundtland served as UN Special Envoy on Climate Change from 2007 to 2012, seeking ways to balance human enterprise and the planet’s limits. As Deputy Chair of The Elders, an independent group of global leaders who work together for peace and human rights founded by Nelson Mandela and currently chaired by Kofi Annan, Dr. Brundtland contributes her experience and independent leadership to tackling the world’s toughest problems.
Theodore (Ted) K. Courtney, MS, CSP, is Director of the Center for Injury Epidemiology at the Liberty Mutual Research Institute for Safety (LMRIS) in Hopkinton, MA, where he is also responsible for Institute-wide extramural research. He is also Instructor on Injury, Safety and Ergonomics in the Department of Environmental Health at HSPH and a core faculty member of the Harvard Education and Research Center. Prior to joining Liberty Mutual and HSPH in the 1990s, he was on faculty at the Georgia Institute of Technology in Atlanta. Mr. Courtney has received the 2003 William Floyd Medal (Ergonomics Society), the 2006 NORA Partnering Award (CDC-NIOSH), and the 2008 Best in Paper Ergonomics Award for his collaborative slips and falls research but is also published in epidemiology of injury, fatigue and safety, musculoskeletal disorders, injury surveillance, injury research methods, safety climate, obesity, and injury morbidity/mortality studies of national and international worker populations. He serves as associate editor of Accident Analysis and Prevention and on the editorial board of the Journal of Occupational and Environmental Hygiene. Mr. Courtney brings nearly two decades of personal perspective on the more than 75 year collaborative relationship between LMRIS and HSPH.
Her Excellency Suraya Dalil, MPH ’05, has served as Minister of Public Health in Afghanistan since 2010. Born in Kabul, she studied medicine at Kabul Medical University and graduated with highest honors and first in her class. She worked with Médecins Sans Frontières in Mazar-e-Sharif in the early 1990s, providing health care services to thousands of Tajik refugees who had fled fighting in Tajikistan. Dr. Dalil worked on a large-scale measles and polio immunization program managed by UNICEF, which vaccinated thousands of children in Afghanistan. In 1998, she and her family were forced to leave Mazar-e-Sharif for Pakistan to escape fighting, and there she continued working with UNICEF’s Afghanistan Office. When she returned to Afghanistan, she participated in the Afghanistan Maternal Mortality Study, one of the most important public health studies in Afghanistan’s recent history. In 2004, Dr. Dalil was awarded a Presidential Scholarship to study at Harvard School of Public Health, and after earning her master’s in health care management and policy, she continued her work in Afghanistan with UNICEF as Head of Policy and Training. She realized that as Afghanistan built a new health care system, the country needed to involve as many Afghans as possible.
Douglas Dockery, SM ’74, SD ’79, Chair, Department of Environmental Health at HSPH and Director, Harvard-NIEHS Center for Environmental Health, has studied the harmful effects of air pollution on cardiovascular and respiratory health for over three decades. As a principal investigator for the landmark Six Cities Study, Dockery and colleagues demonstrated that fine particulate air pollution substantially reduces life expectancy – results which have heavily influenced regulations for the U.S. Clean Air Act and air pollution regulations globally. The paper in which Dockery published these results is one of the most-cited papers on air pollution in the peer-reviewed literature. His current research expands upon this work, attempting to identify the chemical and physical characteristics of dangerous particles, as well as the health benefits of air pollution controls. Read about the impact of the Six Cities study.
Harvey Fineberg, MD ’72, PhD ’80, is President of the Institute of Medicine. He served as Provost of Harvard University from 1997 to 2001, following thirteen years as Dean of the Harvard School of Public Health. He has devoted most of his academic career to the fields of health policy and medical decision making, including assessment of medical technology, evaluation and use of vaccines, and dissemination of medical innovations. Dr. Fineberg helped found and served as president of the Society for Medical Decision Making and has been a consultant to the World Health Organization. He serves on the boards of the William and Flora Hewlett Foundation, the Carnegie Endowment for International Peace, the Josiah Macy Jr. Foundation, The China Medical Board, and the Association François-Xavier Bagnoud (USA). Dr. Fineberg is co-author of the books Clinical Decision Analysis, Innovators in Physician Education, and The Epidemic that Never Was; has co-edited books on such diverse topics as AIDS prevention, vaccine safety, and understanding risk in society; and authored numerous articles published in professional journals. He earned his bachelor’s degree and doctoral degrees from Harvard University.
Julio Frenk, MD, PhD, MPH is dean of the faculty at Harvard School of Public Health and T & G Angelopoulos Professor of Public Health and International Development, a joint appointment between the Harvard Kennedy School of Government and HSPH. Dr. Frenk served as the Minister of Health of Mexico from 2000 to 2006, during which time universal health insurance was introduced. He has also held leadership positions at the National Institute of Public Health of Mexico, the Mexican Health Foundation, the World Health Organization, the Bill and Melinda Gates Foundation, and the Carso Health Institute. He is a member of the Institute of Medicine, the American Academy of Arts and Sciences, and the National Academy of Medicine of Mexico. In September of 2008, Dr. Frenk received the Clinton Global Citizen Award for changing “the way practitioners and policymakers across the world think about health.”
Sarah Fortune, MD, Melvin J. and Geraldine L. Glimcher Associate Professor of Immunology and Infectious Diseases at HSPH, is a leading microbiologist working to determine why the tuberculosis bacterium is increasingly resistant to drug treatment. Fortune’s work has broad reach. While fewer than 10,000 cases are diagnosed annually in the US, tuberculosis remains a deadly global pandemic, sickening 15 million and killing 1.4 million annually. Fortune and her team use creative ways to amass huge amounts of new information on the disease with the potential for important new discoveries. For example, to understand how the bacteria evade antibiotic killing, she and her team captured thousands of images of the bacteria’s random replication patterns every few days – thereby producing a massive amount of data requiring massive labor to analyze. Fortune, a 2010 PopTech Science and Public Leadership Fellow, turned to crowdsourcing for assistance analyzing this data, putting out a call for help before the PopTech conference’s audience of innovators. Learn more.
George Graziani, FSA, FCIA, is Senior Vice President, Head Longevity for North America and the English Caribbean for the Swiss Re Group. Since 1992 he has modeled, structured, and executed insurance, reinsurance, and related capital market transactions. Based in Toronto, George works on both transactional and developmental aspects of longevity, helping clients understand and hedge their longevity exposures through customized value-added solutions. He is a frequent speaker at industry events and is regularly published in the trade press. Prior to joining Swiss Re, George was the vice chairman of Insurance Capital Markets Holdings Ltd. (ICMH), an asset manager and consultant specializing in derivative and cash based strategies in the micro longevity sector. Before ICMH, George priced, traded and structured longevity transactions for International Life Advisors Ltd., a Bermuda based subsidiary of Life Equity. Prior to joining Life Equity, George was the marketing director and actuary for BMO FG’s offshore reinsurance business domiciled in Barbados supported by an $800 million balance sheet, and was the director of Corporate Insurance for BMO FG in Toronto.
David Hunter, MPH ’85, SD ’88, Vincent L. Gregory Professor in Cancer Prevention and dean for academic affairs, is a leader in both cancer research and educational innovation at Harvard School of Public Health. He is Director of HSPH’s Program in Molecular and Genetic Epidemiology, principal investigator in a number of ongoing breast and prostate cancer studies, co-chair of the Steering Committee of the National Cancer Institute (NCI) Breast and Prostate Cancer Cohort Consortium, and former Co-director of the NCI Cancer Genetic Markers of Susceptibility Special Initiative. Dean Hunter serves on the advisory group for the Harvard Initiative for Learning and Teaching, a university-wide effort to catalyze innovation and excellence in learning and teaching at Harvard, has led HSPH strategy to be an early adopter of the HarvardX/EdX platform, and chairs HSPH’s Education Council, which oversees the educational transformations in progress at the School.
Ashish Jha, MD, MPH ’04, professor of health policy and management, is a practicing internist and an influential health policy researcher, informed in his views on health care quality improvement by his work in the trenches of health care delivery. Since 2008, Dr. Jha has served as a special advisor to the Secretary of the Department of Veterans Affairs in Washington, DC. In this role and in his clinical appointment at the Boston VA Health System, he tirelessly advocates for transparency and has stimulated improvements in the quality of health care for veterans. Dr. Jha champions an evidence-driven approach to fixing failing health systems, asserting that “evidence and data can move the world and shape policies to be far more effective.” He is an expert on the role of health information technology in driving improvements in care, and how organizational leadership affects the delivery of safe, effective, and efficient care. Dr. Jha writes the highly respected blog “An Ounce of Evidence,” focusing on bringing data into health policy analysis. Read the blog.
Howard Koh, MD, MPH has served as the 14th Assistant Secretary for Health for the U.S. Department of Health and Human Services (HHS) since 2009. Dr. Koh oversees 12 offices, including the Office of the Surgeon General, the Commissioned Corps of the U.S. Public Health Service, 10 Regional Health Administrators across the country and 10 presidential and secretarial advisory committees. He also serves as senior public health advisor to the Secretary. The Office of Assistant Secretary for Health specifically includes an array of interdisciplinary programs focused on disease prevention, health promotion, the reduction of health disparities, women’s and minority health, adolescent health, HIV/AIDS, vaccine programs, physical fitness and sports, bioethics, population affairs, blood supply, research integrity and human research protections. Dr. Koh previously served as the Harvey V. Fineberg Professor of the Practice of Public Health, Associate Dean for Public Health Practice, and Director of the Division of Public Health Practice at Harvard School of Public Health. Before joining HSPH, he was Commissioner of Public Health for the Commonwealth of Massachusetts from 1997 to 2003. Dr. Koh received his undergraduate and medical degrees from Yale University, and completed postgraduate training at Boston City Hospital and Massachusetts General Hospital, serving as chief resident in both hospitals. He has board certification in internal medicine, hematology, medical oncology, and dermatology, as well as an MPH degree from Boston University. He has earned numerous awards and honors for interdisciplinary accomplishments in medicine and public health, including the Distinguished Service Award from the American Cancer Society (ACS), and was named by the New England Division of the ACS as “one of the most influential persons in the fight against tobacco during the last 25 years.”
Ian Lapp, PhD, associate dean for strategic educational initiatives, arrived at HSPH in 2011 after spending 10 years as associate dean for academic affairs and education at Columbia University’s Mailman School of Public Health, where he led efforts to help revamp that school’s curriculum. Lapp was appointed in 2012 to the field’s accrediting body, the Council on Education for Public Health. For the past two years, he has led HSPH’s “Roadmap to 2013,” an educational strategy effort leading up to the School’s centennial in which faculty and deans seek to define the future of public health education. The Roadmap effort will result in the establishment in 2014 of a new leadership doctor of public health degree for public health practitioners, the redesign of the School’s master’s programs, and the creation of a cross-departmental PhD in population health sciences for those pursuing academic careers. Lapp also heads the School’s new endeavors in educational technology, the flagship of which is its participation in HarvardX, a massive open online course platform offering free university-level courses to a global audience. Learn more.
Dariush Mozaffarian, MD, DPH ’06, is a cardiologist and epidemiologist; Co-Director of the Program in Cardiovascular Epidemiology (www.hsph.harvard.edu/research/cvdepi/); and Associate Professor of Medicine and Epidemiology in the Division of Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School; and Department of Epidemiology, Harvard School of Public Health. Dr. Mozaffarian holds a BS in biological sciences from Stanford (with Honors, Phi Beta Kappa), an MD from Columbia (Alpha Omega Alpha), an MPH from University of Washington, and a Doctorate in Epidemiology from Harvard. His research focuses on effects of lifestyle, particularly diet, on cardiovascular health and disease in the US and globally. Dr. Mozaffarian has authored or co-authored nearly 200 scientific publications on lifestyle and cardiovascular health, including on global dietary burdens of disease, fish and omega-3 fats, trans fats, diets and weight gain, and healthy diet patterns. He has served on numerous committees and advisory boards, including for the World Health Organization, United Nations Food and Agriculture Organization, and American Heart Association.
Kelechi Ohiri, MPH ’02, SM ’03, is Senior Adviser to the Minister in the Federal Ministry of Health of Nigeria. In addition to his strategic advisory role, he serves as the National Coordinator for the Saving One Million Lives Initiative launched by the President of Nigeria. In this position, he has followed his passion for improving health outcomes through the program’s focus on improving access to primary care; improving quality of care through better clinical governance; and unlocking the potential of Nigeria’s private health sector. He also works on broader social policy issues, including social safety nets and poverty reduction programs. He was previously with the London office of McKinsey and Company, where he served a broad section of healthcare clients. Prior to joining McKinsey, he worked with the World Bank as part of the highly selective Young Professionals Program. There he focused on global health programs and on strengthening health systems in South Asia, the Middle East and Africa. He also worked as a Healthcare Management Fellow at Harvard University and as a primary care physician in various settings. In addition to serving on several expert advisory panels, Dr Ohiri has written published numerous papers and co-authored two books on health systems. He currently serves on the boards of the World Health Organization’s Alliance for Health Policy and Systems Research and of the Nigeria Hub for the Centre for Health Markets Innovation.
His Excellency Dr. Pradit Sintavanarong, MPH ’89 was appointed as Minister of Public Health for the Kingdom of Thailand in October 2012. Among his accomplishments in the short time since he became Minister, he has presided over a massive campaign with over a million volunteers to fight a record epidemic of dengue fever, worked to promote the health of millions of migrant workers in Thailand, and supported cooperation on Universal Health Coverage in the Greater Mekong Subregion. He was awarded the World Health Organization Director-General’s Special Award for World No Tobacco Day 2013. Minister Pradit’s clinical background is in drug addiction; he completed his clinical fellowships in psychiatry at McLean Hospital/Harvard Medical School and has coauthored several articles on drug and alcohol dependency. He served as an advisor for the National Command Centre for Combating Drugs from its formation in 2011 until his appointment as Minister of Public Health. Prior to his appointment, Minister Pradit he had a 20-year career in industry, serving as the managing director of Décor Mart Company Ltd. and on a number of corporate boards, most recently Thai Airways International.